中华骨科杂志
中華骨科雜誌
중화골과잡지
CHINESE JOURNAL OF ORTHOPAEDICS
2010年
11期
1151-1156
,共6页
脊髓损伤%格列本脲%大鼠
脊髓損傷%格列本脲%大鼠
척수손상%격렬본뇨%대서
Spinal cord injuries%Glyburide%Rats
目的 探讨格列本脲对大鼠脊髓损伤后继发性损害的保护作用.方法 90只SD大鼠随机分为3组,每组30只,即单纯椎板切除组(对照组)、脊髓损伤组(损伤组)与脊髓损伤后格列本脲治疗组(治疗组).HE染色及电镜观察脊髓损伤后病理变化;免疫组织化学法检测脊髓损伤后45min、6 h、24 h、3 d、7 d的磺脲类药物受体1(sulfonylurea receptor type 1,SUR1)表达变化,利用IPP 6.0软件对SUR1的表达进行定量分析.采用BBB评分评价大鼠后肢功能的恢复.并对大鼠血糖进行定量检测.结果 HE染色显示:脊髓损伤后脊髓出血和胶质细胞增生随时间延长而加重,治疗组的组织出血、小胶质细胞增生和中性粒细胞浸润均较损伤组轻.电镜观察:治疗组的炎症细胞浸润、髓鞘板层结构破坏及线粒体肿胀程度等均较损伤组明显减轻.免疫组织化学染色显示:除45 min时SUR1尚未表达外,其余各时间点治疗组的SUR1表达均较损伤组弱.术后24 h,损伤组SUR1表达达高峰,此后随时间逐渐下降.三组各时间点的SUR1平均光密度经单因素方差分析,差异有统计学意义.治疗组大鼠BBB评分明显高于损伤组大鼠,各组差异有统计学意义.治疗组大鼠的血糖稍下降,但三组差异并无统计学意义.结论 格列本脲治疗能显著减轻脊髓的继发性损伤,促进脊髓功能恢复.格列本脲通过抑制SUR1的表达而发挥脊髓保护作用.
目的 探討格列本脲對大鼠脊髓損傷後繼髮性損害的保護作用.方法 90隻SD大鼠隨機分為3組,每組30隻,即單純椎闆切除組(對照組)、脊髓損傷組(損傷組)與脊髓損傷後格列本脲治療組(治療組).HE染色及電鏡觀察脊髓損傷後病理變化;免疫組織化學法檢測脊髓損傷後45min、6 h、24 h、3 d、7 d的磺脲類藥物受體1(sulfonylurea receptor type 1,SUR1)錶達變化,利用IPP 6.0軟件對SUR1的錶達進行定量分析.採用BBB評分評價大鼠後肢功能的恢複.併對大鼠血糖進行定量檢測.結果 HE染色顯示:脊髓損傷後脊髓齣血和膠質細胞增生隨時間延長而加重,治療組的組織齣血、小膠質細胞增生和中性粒細胞浸潤均較損傷組輕.電鏡觀察:治療組的炎癥細胞浸潤、髓鞘闆層結構破壞及線粒體腫脹程度等均較損傷組明顯減輕.免疫組織化學染色顯示:除45 min時SUR1尚未錶達外,其餘各時間點治療組的SUR1錶達均較損傷組弱.術後24 h,損傷組SUR1錶達達高峰,此後隨時間逐漸下降.三組各時間點的SUR1平均光密度經單因素方差分析,差異有統計學意義.治療組大鼠BBB評分明顯高于損傷組大鼠,各組差異有統計學意義.治療組大鼠的血糖稍下降,但三組差異併無統計學意義.結論 格列本脲治療能顯著減輕脊髓的繼髮性損傷,促進脊髓功能恢複.格列本脲通過抑製SUR1的錶達而髮揮脊髓保護作用.
목적 탐토격렬본뇨대대서척수손상후계발성손해적보호작용.방법 90지SD대서수궤분위3조,매조30지,즉단순추판절제조(대조조)、척수손상조(손상조)여척수손상후격렬본뇨치료조(치료조).HE염색급전경관찰척수손상후병리변화;면역조직화학법검측척수손상후45min、6 h、24 h、3 d、7 d적광뇨류약물수체1(sulfonylurea receptor type 1,SUR1)표체변화,이용IPP 6.0연건대SUR1적표체진행정량분석.채용BBB평분평개대서후지공능적회복.병대대서혈당진행정량검측.결과 HE염색현시:척수손상후척수출혈화효질세포증생수시간연장이가중,치료조적조직출혈、소효질세포증생화중성립세포침윤균교손상조경.전경관찰:치료조적염증세포침윤、수초판층결구파배급선립체종창정도등균교손상조명현감경.면역조직화학염색현시:제45 min시SUR1상미표체외,기여각시간점치료조적SUR1표체균교손상조약.술후24 h,손상조SUR1표체체고봉,차후수시간축점하강.삼조각시간점적SUR1평균광밀도경단인소방차분석,차이유통계학의의.치료조대서BBB평분명현고우손상조대서,각조차이유통계학의의.치료조대서적혈당초하강,단삼조차이병무통계학의의.결론 격렬본뇨치료능현저감경척수적계발성손상,촉진척수공능회복.격렬본뇨통과억제SUR1적표체이발휘척수보호작용.
Objective To investigate the effects of Glibenclamide on reduction of secondary damage after acute spinal cord injury in rats.Methods Ninety rats were randomly divided into control group (laminectomy alone),spinal cord injury group(injury group),and treatment group(treated with Glibenclamide after spinal cord injury),with 30 rats in each group.The pathological morphology changes of injured spinal cord were observed by HE staining and electron microscope.The expressions of sulfonylurea receptor 1 (SUR1)were detected by immunohistochemical method at 45 min,6 h,24 h,3 d and 7 d after spinal cord injury,and IPP 6.0 software were used for quantitative analysis.The function recoveries of the hind limbs of rats were evaluated by BBB score.The blood sugar level was detected quantitatively.Results HE staining showed that tissue bleeding and microglia proliferation getting severe with time after spinal cord injury.Compared to the injury group,tissue bleeding,microglia proliferation and inflammatory cell invasion was less severe in treatment group.Showed by electron microscope,inflammatory cell invasion,myelin sheath layer structure damage and mitochondrial swelling were significantly reduced after Glibenclamide treatment.Detected by immunohistochemical staining,the expressions of SUR1 at all time points after injury,except for 45 min that there were no SUR1 expressions in all groups,were much weaker in the treatment group than in the injury group.The SUR1 expression reached the peak at 24 h after injury in injury group,and decreased gradually with time.Significant differences were found in the SUR1 expression among three groups by oneway ANOVE.The BBB scores of treatment group were significant higher than that of injury group.The blood sugar slightly decreased in the treatment group,while no significant difference was found among three groups.Conclusion Glibenclamide can significant reduced the secondary damage after acute spinal cord injury.The protection of Glibenclamide after spinal cord injury may relate to its suppression of SUR1.